Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Sterility & contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections.

6,317 FDA drug recalls with this cause, newest first.

This is the single biggest cause in the register by a wide margin. It covers products that had to be sterile - injectables, eye drops, certain ointments - but could not be verified sterile, or were found contaminated during testing. Most of these recalls come from compounding pharmacies and outsourcing facilities after an FDA inspection finds gaps in how sterile products were made. Sterility failures are treated seriously because the products involved have the least room for error, going straight into the bloodstream or the eye.

Class II · Moderate risk

Eyebright Concentrate Topical Eye Rinse

Lack of Assurance of Sterility; Lack of Assurance of Sterility; product not manufactured under sterile conditions as required for ophthalmic drug products

Terminated Sterility / contamination Earthlabs, Inc. DBA Wise Woman Herbals D-912-2013
Class II · Moderate risk

Metronidazole Injection USP

Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Terminated Sterility / contamination Baxter Healthcare Corp. NDC 0338-1055-48 D-629-2013
Class II · Moderate risk

Sodium Chloride Injection

Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Terminated Sterility / contamination Baxter Healthcare Corp. NDC 0338-0049-11 D-628-2013
Class II · Moderate risk

Lidocaine Hydrochloride and 5% Dextrose Injection

Lack of Assurance of Sterilty: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Terminated Sterility / contamination Baxter Healthcare Corp. D-627-2013
Class II · Moderate risk

Heparin Sodium and 0.9% Sodium Chloride Injection

Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Terminated Sterility / contamination Baxter Healthcare Corp. NDC 0338-0433-04 D-626-2013
Class II · Moderate risk

5% Dextrose Injection

Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Terminated Sterility / contamination Baxter Healthcare Corp. NDC 0338-0017-31 D-625-2013
Class II · Moderate risk

0.9% Sodium Chloride Injection

Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Terminated Sterility / contamination Baxter Healthcare Corp. NDC 0338-0553-11 D-624-2013
Class II · Moderate risk

Proplete 45 - 51 KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-592-2013
Class II · Moderate risk

Proplete 90+ KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-591-2013
Class II · Moderate risk

Proplete 80+ KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-590-2013
Class II · Moderate risk

Proplete 70+ KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions

Terminated Sterility / contamination Pentec Health D-589-2013
Class II · Moderate risk

Proplete 60 - 69 KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-588-2013
Class II · Moderate risk

Proplete 52 - 59 KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-587-2013
Class II · Moderate risk

Proplete 40 - 44 KG

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-586-2013
Class II · Moderate risk

Idpn

Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions.

Terminated Sterility / contamination Pentec Health D-585-2013